featured
Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial
JAMA Oncol 2020 Feb 13;[EPub Ahead of Print], F Petrelli, R Labianca, A Zaniboni, S Lonardi, F Galli, E Rulli, G Rosati, S Corallo, M Ronzoni, GG Cardellino, R Mattioli, A Mambrini, L Ciuffreda, M Banzi, V Pusceddu, E Maiello, M Zampino, V Zagonel, P Marchetti, D Corsi, L Rimassa, S Cinieri, A SobreroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.